On July 10th, Spain and Portugal signed an agreement to strengthen their collaboration in healthcare matters, with particular emphasis on developing common, shared procedures for P&R and centralised purchasing of medicinal products and medical devices. This collaboration will kick-off with a pilot programme using a biosimilar product which, if considered positive by both countries, could bring important changes to P&R and market access procedures to be followed in both countries.
Please check the detail of the news from here (only in Spanish)